Terug
Dagbereik
€ 31,34
€ 32,57
52-Weeksbereik
€ 19,34
€ 37,57
Volume
545.508
50D / 200D Gem.
€ 33,83
/
€ 29,01
Vorige Slotkoers
€ 31,78
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -8,1 | 0,4 |
| P/B | 11,2 | 2,9 |
| ROE % | -81,2 | 3,7 |
| Net Margin % | -18,6 | 3,8 |
| Rev Growth 5Y % | 12,9 | 10,0 |
| D/E | 13,5 | 0,2 |
Belangrijkste Punten
Revenue grew 12,88% annually over 5 years — strong growth
Debt/Equity of 13,46 — high leverage
Negative free cash flow of -8,92M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 12,36%
Capital efficient — spends only 8,73% of revenue on capex
Groei
Revenue Growth (5Y)
12,88%
Revenue (1Y)25,24%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-81,23%
ROIC-5,89%
Net Margin-18,57%
Op. Margin-15,27%
Veiligheid
Debt / Equity
13,46
Current Ratio0,74
Interest Coverage-1,51
Waardering
P/E Ratio
-8,09
P/B Ratio11,17
EV/EBITDAN/A
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 25,24% | Revenue Growth (3Y) | 22,18% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12,88% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 381,14M | Net Income (TTM) | -70,78M |
| ROE | -81,23% | ROA | -8,38% |
| Gross Margin | -7,97% | Operating Margin | -15,27% |
| Net Margin | -18,57% | Free Cash Flow (TTM) | -8,92M |
| ROIC | -5,89% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 13,46 | Current Ratio | 0,74 |
| Interest Coverage | -1,51 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | -8,09 | P/B Ratio | 11,17 |
| P/S Ratio | 1,50 | PEG Ratio | -0,01 |
| EV/EBITDA | N/A | Dividend Yield | 0,01% |
| Market Cap | 572,28M | Enterprise Value | 1,25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 381,14M | 304,33M | 255,32M | 238,43M | 234,72M |
| Net Income | -70,78M | -2,06M | -21,11M | -54,40M | 125,61M |
| EPS (Diluted) | -4,22 | -0,54 | -3,85 | -9,27 | 37,92 |
| Gross Profit | -30,37M | 271,23M | 234,22M | 211,06M | 193,82M |
| Operating Income | -58,21M | -14,83M | -15,19M | -29,31M | -33,65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 844,85M | 841,92M | 621,46M | 661,27M | 728,55M |
| Total Liabilities | 788,59M | 712,31M | 688,01M | 719,43M | 734,11M |
| Shareholders' Equity | 51,24M | 123,03M | -66,55M | -58,16M | -5,56M |
| Total Debt | 689,74M | 651,39M | 629,42M | 671,03M | 683,68M |
| Cash & Equivalents | 11,01M | 16,99M | 4,08M | 16,91M | 78,69M |
| Current Assets | 77,88M | 64,09M | 32,35M | 43,57M | 106,19M |
| Current Liabilities | 105,13M | 75,62M | 100,86M | 94,32M | 120,48M |